Europe’s approach to nicotine risk appears to be sending mixed signals. On 16 September, the European Parliament adopted its cardiovascular health strategy, in which differences in nicotine products and their risk profiles were recognised. Less than two weeks later, Parliament’s Committee on Public Health (SANT) adopted its report on the implementation of Europe’s Beating Cancer…
As the popularity of alternative nicotine products continues to grow, understanding their safety and legal regulations is critical for both consumers and policymakers. Proper use and adherence to safety guidelines ensure that these products serve as effective tools for harm reduction while minimizing risks. Legal Regulations The legal landscape for nicotine products varies across regions.…
Nicotine has long been at the center of debates surrounding smoking and its associated health risks. However, widespread misinformation—or disinformation, as it is often deliberately designed to confuse the public and consumers—continues to obscure the facts about nicotine’s actual role in tobacco-related diseases. By addressing these myths and focusing on evidence-based knowledge, we can improve…